Technology Insight: Magnetic resonance angiography for the evaluation of patients with peripheral artery disease

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 12, 2007, Pages 677-687

  Dellegrottaglie, Santo ^a   Sanz, Javier ^a   Macaluso, Frank ^a   Einstein, Andrew J ^b   Raman, Subha ^d   Simonetti, Orlando P ^c   Rajagopalan, Sanjay ^d  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c Cardiovascular MRI and CT Research

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM CHELATE;

ANAMNESIS; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ATHEROSCLEROSIS; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER PROGRAM; CONTAMINATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; HUMAN; INTERMETHOD COMPARISON; LIMB ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; REVIEW; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

ATHEROSCLEROSIS; HUMANS; LOWER EXTREMITY; MAGNETIC RESONANCE ANGIOGRAPHY; PERIPHERAL VASCULAR DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 36448934548     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1035     Document Type: Review

References (69)

1. Ouriel K (2001) Peripheral arterial disease. Lancet 358: 1257-1264
2. Hirsch AT et al. (2006) ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113: E463-e654
3. Criqui MH et al. (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326: 381-386
4. Papamichael CM et al. (2000) Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 86: 615-618
5. McDermott MM et al. (2004) Functional decline in peripheral arterial disease: Associations with the ankle brachial index and leg symptoms. JAMA 292: 453-461
6. Gale SS et al. (1998) Lower extremity arterial evaluation: Are segmental arterial blood pressures worthwhile? J Vasc Surg 27 831-838
7. Prince MR et al. (1993) Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging 3: 877-881
8. Rubin GD et al. (2001) Multi-detector row CT angiography of lower extremity arterial inflow and runoff: Initial experience. Radiology 221: 146-158
9. Yuan C et al. (2001) Carotid atherosclerotic plaque: Noninvasive MR characterization and identification of vulnerable lesions. Radiology 221: 285-299
10. Fayad ZA et al. (2000) Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102: 506-510
11. Fayad ZA et al. (2000) In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: A comparison with transesophageal echocardiography. Circulation 101: 2503-2509
12. Tirivedi RA et al. (2004) MRI-derived measurements of fibrous-cap and lipid-core thickness. the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 46: 738-743
13. Yuan C et al. (2001) In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104: 2051-2056
14. Coulden RA et al. (2000) High resolution magnetic-resonance imaging of atherosclerosis and the response to balloon angioplasty. Heart 83: 188-191
15. Heverhagen JT et al. (2000) Quantitative human in vivo evaluation of high resolution MRI for vessel wall morphometry after percutaneous transluminal angioplasty. Magn Reson Imaging 18 985-989.
16. Meissner OA et al. (2003) High-resolution MR imaging of human atherosclerotic femoral arteries in vivo: Validation with intravascular ultrasound. J Vasc Interv Radiol 14: 227-231
17. Wyttenbach R et al. (2004) Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 110; 1156-1161
18. McCauley TR et al. (1994) Peripheral vascular occlusive disease: accuracy and reliability of time-of-flight MR angiography. Radiology 192: 351-357
19. Goyen M et al. (2005) MR angiography of aortoiliac occlusive disease: A phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 236: 825-833
20. Tongdee R et al. (2006) Hybrid peripheral 3D contrast-enhanced MR angiography of calf and foot vasculature. AJR Am J Roentgenol 186: 1746-1753
21. Lelner T et al. (2004) Comparison of contrast-enhanced magnetic resonance anglography and digital subtraction angiography in patients with chronic critical ischemia and tissue loss. Invest Radiol 39: 435-444
22. Korosec FR et al. (1996) Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 36: 345-351
23. Du J et al. (2002) Time-resolved, undersampled projection reconstruction imaging for high-resolution CE-MRA of the distal runoff vessels. Magn Reson Med 48: 516-522
24. Madhuranthakam AJ et al. (2004) Time-resolved 3D oontrast-enhanced MRA of an extended FOV using continuous table motion. Magn Reson Med 51: 568-576
25. Zhang HL et al. (2004) Decreased venous contamination on 3D gadolinium-enhanced bolus chase peripheral MR angiography using thigh compression. AJR Am J Roentgenol 183: 1041-1047
26. Vogt FM et al. (2004) Venous compression at high-spatial-resolution three-dimensional MR angiography of peripheral arteries. Radiology 233: 913-920
27. Goyen M et al. (2002) Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole-body 3D magnetic resonance angiography. Invest Radiol 37: 263-268
28. Khan NA et al. (2006) Does the clinical examination predict lower extremity peripheral arterial disease? JAMA 295: 536-546
29. Dormandy JA and Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31 (Suppl): S1-S296
30. Bertschinger K et al. (2001) Surveillance of peripheral arterial bypass grafts with three-dimensional MR angiography: Comparison with digital subtraction angiography. AJR Am J Roentgenol 176: 215-220
31. Hofmann WJ et al. (2002) Pedal artery imaging-a comparison of selective digital subtraction angiography, contrast enhanced magnetic resonance angiography and duplex ultrasound. Eur J Vasc Endovasc Surg 24: 287-292
32. Dorweller B et al. (2002) Magnetic resonance angiography unmasks reliable target vessels for pedal bypass grafting in patients with diabetes mellitus. J Vasc Sung 35: 766-772
33. Lapeyre M et al. (2005) Assessment of critical limb ischemia in patients with diabetes: Comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol 185: 1641-1650
34. Eiberg JP et al. (2001) Peripheral vascular surgery and magnetic resonance arteriography - a review. Eur J Vasc Endovasc Surg 22 396-402
35. Steffens JC et al. (2003) Bolus-chasing contrast-enhanced 3D MRA of the lower extremity: Comparison with intraarterial DSA. Acta Radiol 44: 185-192
36. Goyen M and Debatin JF (2004) Gadopentetate dimeglumine-enhanced three-dimensional MR-angiography: Dosing, safety, and efficacy. J Magn Reson Imaging 19: 261-273
37. Storto ML and Battista D (2003) Advances in vascular and cardiac MDCT imaging: Peripheral arteries. Eur Radiol 13 (Suppl 3): N59-N62
38. Jakobs TF et al. (2004) MDCT-imaging of peripheral arterial disease. Semin Ultrasound CT MR 25:, 145-155
39. Ota H et al. (2004) MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: Importance of reviewing cross-sectional images. AJR Am J Roentgenol 182: 201-209
40. O'Hare AM et al. (2005) Low ankle-brachial index associated with rise in creatinine level over time: Results from the atherosclerosis risk in communities study. Arch Intern Med 165: 1481-1485
41. Ouwendijk R et al. (2605) Interobserver agreement for the interpretation of contrast-enhanced 3D MR angiography and MDCT angiography in peripheral arterial disease. AJR Am J Roentgenol 185: 1261-1267
42. Roth SM and Bandyk DF (1999) Duplex imaging of lower extremity bypasses, angioplasties, and stents. Semin Vasc Surg 12: 275-284
43. Leiner T et al. (2005) Peripheral arterial disease: Comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology 235: 699-708
44. Gjonnaess E et al. (2006) Gadolinium-enhanced magnetic resonance angiography, colour duplex and digital subtraction angiography of the lower limb arteries from the aorta to the tiblo-peroneal trunk in patients with Intermittent claudication. Eur J Vasc Endovasc Surg 31: 53-58
45. Goyen M et al. (2002) Whole-body three-dimensional MR anglography with a rolling table platform: Initial clinical experience. Radiology 224: 270-277
46. Goyen M et al. (2003) Detection of atherosclerosis: Systemic imaging for systemic disease with whole-body three-dimensional MR angiography - initial experience. Radiology 227: 277-282
47. Ruehm SG et al. (2001) Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 357: 1086-1091
48. Fenchel M et al. (2005) Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: First clinical experience. J Magn Reson Imaging 21: 596-603
49. Pennell DJ etal. (2004) Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 25: 1940-1965
50. Rofsky NM et al. (1997) Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography. Radiology 205 163-169
51. Yamashita Y et al. (1998) Three-dimensional high-resolution dynamic contrast-enhanced MR angiography of the pelvis and lower extremities with use of a phased array coil and subtraction: Diagnostic accuracy. J Magn Reson Imaging 8: 1066-1072
52. Ho KY et al. (1998) Peripheral vascular tree stenoses: Evaluation with moving-bed infusion-tracking MR angiography. Radiology 206 683-692.
53. Sueyoshi E et al. (1999) Aortoiliac and lower extremity arteries: comparison of three-dimensional dynamic contrast-enhanced subtraction MR angiography and conventional angiography. Radiology 210: 683-688
54. Meaney JF et al. (1999) Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 211: 59-67
55. Winterer JT et al. (1999) Contrast-enhanced subtraction MR angiography in occlusive disease of the pelvic and lower limb arteries: results of a prospective intraindividual comparative study with digital subtraction angiography in 76 patients. J Comput Assist Tomogr 23: 583-689
56. Ruehm SG et al. (2000) Pelvic and lower extremity arterial imaging: Diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol 174: 1127-1135
57. Huber A et al. (2000) Dynamic contrast-enhanced MR angiography from the distal aorta to the ankle joint with a step-by-step technique. AJR Am J Roentgenol 175: 1291-1298
58. Loewe C et al. (2002) Peripheral vascular occlusive disease: evaluation with contrast-enhanced moving-bed MR angiography versus digital subtraction angiography in 106 patients. AJR Am J Roentgenol 179: 1013-1021
59. Hentsch A et al. (2003) Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: A prospective, multicentre blinded comparison with digital subtraction angiography. Eur Radiol 13: 2103-2114
60. Herborn CU et al. (2004) Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. AJR Am J Roentgenol 182: 1427-1434
61. Krause U et al. (2005) Contrast-enhanced magnetic resonance angiography of the lower extremities: Standard-dose vs. high-dose gadodiamide injection. J Magn Reson Imaging 21: 449-454
62. Janke R et al. (2005) Contrast-enhanced MR angiography of peripheral arteries including pedal vessels at 1.0 T: Feasibility study with dedicated peripheral angiography coil. Radiology 235: 319-326
63. Fenchel M et al. (2006) Atherosclerotic disease: Whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology - initial clinical results. Radiology 238: 280-291
64. Quick HH et al. (2004) High spatial resolution whole-body MR angiography featuring parallel imaging: Initial experience [German]. Rofo 176: 163-169
65. Herborn CU et al. (2004) Peripheral vasculature: Whole-body MR angiography with midfemoral venous compression - initial experience. Radiology 230: 872-878
66. Ruehm SG et al. (2004) Whole body MR angiography screening. Int J Cardiovasc Imaging 20: 587-591
67. Brennan DD et al. (2005) Contrast-enhanced boluschased whole-body MR angiography using a moving tabletop and quadrature body coil acquisition. AJR Am J Roentgenol 185: 750-755
68. Kramer H et al. (2005) Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology 236 300-310
69. Hansen T et al. (2006) Whole-body magnetic resonance angiography of patients using a standard clinical scanner. Eur Radiol 16 147-153